Activist Starboard Trailed Peers With Less Than 5% Returns
Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large ...
Pfizer names former FDA director as chief medical officer
Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...
Can this covid-times saviour navigate the self-inflicted deep slump?
The all-or-nothing strategy has landed the ‘pride of the pharmaceutical industry' in a situation that deteriorated rapidly.
Starboard Value buys Pfizer, exits Humana in Q4
Jeffrey Smith’s Starboard Value disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth quarter ...
Business Insider13d
Starboard Value buys Pfizer, exits Humana in Q4
Starboard’s top holdings as of December 31, in order of size, were GoDaddy (GDDY), Gen Digital (GEN), Match Group, Kenvue, and Pfizer. Leverage the power of TipRanks' Smart Score, a data-driven ...
pharmaphorum3d
Starboard spells out its concerns with Pfizer's direction
Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...
Yahoo Finance22d
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
That Pfizer’s turnaround is already well underway is reflected by the fact that activist investor Starboard Value, led by Jeffrey Smith, wisely chose not to nominate any dissident directors to ...
The Industry Veteran CEO: Friend Or Foe?
Director nominees with CEO experience have long featured in Board slates put forward by activist investors. Those candidates were typically from outs ...
pharmaphorum9d
Ex-Pfizer leaders side with firm against activist investor
Two former Pfizer executives drawn into a campaign by activist investor Starboard Value to shake up the company have withdrawn their support for the plan. Pfizer's ex-chair and chief executive Ian ...
ETF Daily News6d
Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of “Moderate Buy” from Analysts
Starboard Value LP bought a new stake in shares of Pfizer in the 4th quarter valued at $407,730,000. Raymond James Financial Inc. bought a new stake in shares of Pfizer in the 4th quarter valued ...
Crain's New York23d
Pfizer gets unexpected boost from Covid vaccine and pill
Pfizer got a reprieve in late January when Starboard did not nominate its own slate of directors to the company’s board, but the activist could still agitate for changes in 2026. Among Pfizer ...
NBC New York23d
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
Pfizer appears to have dodged a proxy battle with activist investor Starboard Value, which has a roughly $1 billion stake in the pharmaceutical giant, for now. The deadline passed for nominating ...